PARI
Arne W. Dirks is currently the Chief Executive Officer at PARI since April 2022. Their previous experience includes working at AstraZeneca, where they held various roles from 2005 to 2021. Arne W. served as the Vice President - Executive Officer of the Respiratory & Immunology Business Unit from April 2019 to December 2021. Prior to that, they were the Global Commercial Head of the Neuroscience and Pain Franchise from July 2016 to March 2019, and the Global Commercial Head of the Gout Franchise in January 2016. Arne W. also worked as a Senior Marketing Director for various departments such as Antithrombotic, Gastrointestinal, Respiratory, Inflammation & Autoimmunity from August 2013 to December 2015. Before that, they held positions such as Business Director, Associate Director, and First Line Sales Manager at AstraZeneca. Arne W. Dirks started their career as a Pharma Sales Rep at AstraZeneca in July 2005 after receiving training at IHK.
Arne W. Dirks has pursued education in various institutions, with a focus on business and leadership. Arne has completed the Transition to General Management (TGM FS) program at INSEAD, which provided valuable insights into the field of general management. Additionally, Arne has studied Enterprise Transformation Leadership at the Massachusetts Institute of Technology, specializing in driving and leading organizational change. Alongside these ventures, Arne has also pursued studies in Business Administration/ International Management at Northumbria University.
This person is not in any teams
PARI
1 followers
PARI was founded in Wuppertal in 1906 and has progressed during its more than 100 years of company history from a small manufacturer to a globally respected specialist in respiratory therapy. At present, the PARI business group is headquartered in Starnberg, Germany with additional locations in Weilheim, Germany (PARItec, production) and Gräfelfing, Germany (PARI Pharma, medicinal products and eFlow technology). In addition, there are international branch offices and a worldwide distribution network. As a manufacturer of medical devices with a focus on respiratory therapy, PARI has been the brand to trust for doctors, pharmacists and patients, for many decades. Continuous development and steady growth enabled PARI to expand their market leadership in Germany for equipment, saline solutions and respiratory aids. PARI is the global market leader in the field of nebuliser devices for cystic fibrosis. PARI offers specially optimized devices and solutions for inhalation for pulmonary, bronchial and also nasopharyngeal diseases. A broad portfolio is used to provide patients with comprehensive care, ranging from diagnosis and treatment to monitoring. PARI’s mission is to improve the lives of those affected by respiratory diseases and those who provide care to them. In addition to innovative products and tailored solutions, PARI also offers comprehensive services for users, medical professionals and distribution partners. Are you seeking new career opportunities? Visit our website www.pari.com and find out more about open positions.